Announcements Trials

Browse Landscape

Phase

Status

Withdrawn 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 11 Lymphoma 11 Small Cell Lung Carcinoma 6 Lymphoma, Non-Hodgkin 5 Lymphoma, Follicular 5 Lung Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Carcinoma, Non-Small-Cell Lung 4 Burkitt Lymphoma 4 Lymphoma, Mantle-Cell 3 Lymphoma, Large-Cell, Immunoblastic 3 Lymphoma, Large-Cell, Anaplastic 3 Hodgkin Disease 3 Waldenstrom Macroglobulinemia 2 Sarcoma 2 Recurrence 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, B-Cell, Marginal Zone 2 Lymphoma, AIDS-Related 2 Leukemia, Myeloid, Acute 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Immunoblastic Lymphadenopathy 2 Dendritic Cell Sarcoma, Interdigitating 2 Unspecified Adult Solid Tumor, Protocol Specific 1 Thymoma 1 Testicular Neoplasms 1 Testicular Germ Cell Tumor 1 Sezary Syndrome 1

Interventions

alovudine 1 Radiotherapy 1 Etoposide 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Thymoma × Etoposide × Clear all

NCT02633514 2026-04-27

Adjuvant Treatment for Incomplete Resection Thymoma or Thymic Carcinoma

Fudan University

Phase 3 Withdrawn

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡